T&K (301263.SZ) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Oct28

T&K released FY2025 Q3 earnings on October 28 During-Market (BJT), actual revenue CNY 178.75 M, actual EPS CNY -0.0108

01:00

T&K released FY2025 9 Months earnings on October 28 During-Market (BJT), actual revenue CNY 525.83 M, actual EPS CNY 0.0739

01:00

Oct21

T&K FY2025 Q3 Earnings Release on October 29, 2025 During-Market (BJT)

01:39

Aug20

T&K released FY2025 Q2 earnings on August 20 After-Market (BJT), actual revenue CNY 162.42 M, actual EPS CNY 0.0148

01:00

Aug13

T&K to Release FY2025 Semi-Annual Earnings on August 21, 2025 (BJT)

00:19

Aug4

Taiankang Subsidiary Completes Phase II Clinical Trial Data Unblinding for CKBA Ointment

07:46

Schedules & Filings

Schedules

Filings

Oct28

Earning Release(CST)

FY2025 Q3 Earning Release (CNY) Revenue 178.75 M, Net Income -5.68 M, EPS -0.0108

Aug21

Earning Release(CST)

FY2025 Semi-Annual Earning Release

Aug20

Earning Release(CST)

FY2025 Q2 Earning Release (CNY) Revenue 162.42 M, Net Income 5.539 M, EPS 0.0148

View More

Stock List

Top Gainers

Top Decliners

Northbound Connect

Symbol

Price

%Chg

Change

View More